This AHA scientific statement highlights that pediatric primary hypertension is an underrecognized condition with a prevalence of 2-5%, emphasizing the need for primordial prevention, better diagnosis, and evidence-based treatment.
Answers are grounded in this paper and cite their sources.
Urges primordial prevention and routine screening in children; extends adult risk data to support early pediatric intervention.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Falkner et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: